High risk localized prostate cancer
Clinical trials for High risk localized prostate cancer explained in plain language.
Never miss a new study
Get alerted when new High risk localized prostate cancer trials appear
Sign up with your email to follow new studies for High risk localized prostate cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo before prostate surgery shows promise in early trial
Disease control Recruiting nowThis study tests whether taking darolutamide (a hormone-blocking pill) plus standard hormone therapy for 12 or 24 weeks before prostate removal surgery can reduce or eliminate cancer in men with high-risk localized prostate cancer. About 250 men in China will be randomly assigned…
Matched conditions: HIGH RISK LOCALIZED PROSTATE CANCER
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
700 men with prostate cancer to help shape future treatments
Knowledge-focused Recruiting nowThis study will follow 700 men with high-risk localized or metastatic prostate cancer to collect detailed information on how they are treated in everyday practice. Researchers will track treatments, side effects, quality of life, and disease progression over time. The goal is to …
Matched conditions: HIGH RISK LOCALIZED PROSTATE CANCER
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC